Turn Therapeutics (TTRX) Share-based Compensation (2024 - 2026)
Turn Therapeutics' quarterly Share-based Compensation came in at $155830.0 in Q1 2026, up 103.49% year-on-year from $76580.0 in Q1 2025, and down 39.22% quarter-over-quarter from $256375.0 in Q4 2025.
Turn Therapeutics has reported Share-based Compensation for 3 years, with the latest figure at $155830.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 103.49% year-over-year to $155830.0; the trailing twelve-month figure through Mar 2026 stood at $526598.0 (changed N/A YoY), and the FY2025 full-year result was $419245.0, up 18.82% from the prior year.
- Share-based Compensation for Q1 2026 stood at $155830.0, down from $256375.0 in the prior quarter.
- The five-year high for Share-based Compensation was $256375.0 in Q4 2025, with the low at $37813.0 in Q4 2024.
- Average Share-based Compensation over 3 years is $131649.5, with a median of $116205.0 recorded in 2025.
- Year-over-year, Share-based Compensation surged 578.01% in 2025 and jumped 103.49% in 2026.
- Tracing TTRX's Share-based Compensation over 3 years: stood at $37813.0 in 2024, then surged by 578.01% to $256375.0 in 2025, then plunged by 39.22% to $155830.0 in 2026.
- The last three Share-based Compensation figures came in at $155830.0 (Q1 2026), $256375.0 (Q4 2025), and $76580.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Turn Therapeutics | 188.06 Mn | 188.06 Mn | - | 155,830.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155,830.00 |
| Mar 31, 2026 | 155,830.00 |
| Dec 31, 2025 | 256,375.00 |
| Dec 31, 2025 | 256,375.00 |
| Mar 31, 2025 | 76,580.00 |
| Mar 31, 2025 | 76,580.00 |
| Dec 31, 2024 | 37,813.00 |
| Dec 31, 2024 | 37,813.00 |